Kegler George A. 4

What Happened George A. Kegler, a director of Enveric Biosciences, received a restricted stock award of 18,518 shares on June 1, 2026. The award was granted at $0.00 per share (aggregate value reported as $0) under the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan.

Key Details

• Transaction type/code: Award/Grant (A)
• Transaction date: 2026-06-01; Filing date: 2026-06-03 (Form 4 accession: 0001761753-26-000003)
• Shares granted: 18,518; Price per share: $0.00; Aggregate value: $0
• Shares owned after transaction: Not specified in the information provided
• Footnote: The shares are restricted stock granted under the 2020 LTIP and "shall vest in accordance with the terms and conditions of the Plan and the reporting person's restricted stock award agreement" (Footnote F1)
• Timeliness: Filing appears timely (filed within two business days of the reported transaction date)

Context This was a compensation award (restricted stock), not an open-market purchase or sale. Such grants align insider compensation with long-term shareholder value but do not necessarily indicate immediate buying or selling intent—vesting schedules and future Form 4 disclosures (if and when shares vest or are sold) are the best indicators of subsequent insider market activity.